MedTrace Logo

Effect of Allium Cepa in the Management of Shoulder Pain Post Stroke

NCT03468049 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2019-11-06

No results posted yet for this study

Summary

One of the disabling consequences of stroke is hemipleic shoulder pain. Hemiplegic shoulder pain could be most important hinderance to upper extremity function after stroke . Evidence for rehabilitation approaches for shuolder pain suggested diverse approaches with strong need for further studies. This study planned to investigate the effect of Allium Cepa in the management of shoulder pain post stroke using four arms of the studying with three intervention groups and control group All participants who met study inclusion criteria and gave their consent shall be assessed at baseline for impairment (Fugl Meyer Assessment), activity limitation (Brief Pain Inventory) and participation restrictions (Stroke Impact Scale)

Conditions

Interventions

BIOLOGICAL

Topical App. of Allium Cepa Extract

Topical Application of Allium Cepa Extract (oil)

BIOLOGICAL

Phonophoresis of Allium Cepa Extract

Phonophoresis of Allium Cepa Extract (oil)

BIOLOGICAL

Raw Mashed Allium Cepa Application

Raw Allium Cepa (onion bulb) Mashed

OTHER

Standard Physiotherapy Group (SPG)

This will consist of Massage and therapeutic exercise for the management of shoulder pain post stroke

Sponsors & Collaborators

  • Physiotherapy Associates

    collaborator OTHER

  • Bayero University Kano, Nigeria

    lead OTHER

Principal Investigators

  • Isa U Lawal, BSc MSc PhD · Bayero University Kano

  • Hauwa H Mohammed, BMR,MSc · Bayero University Kano

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-11
Primary Completion
2019-06-14
Completion
2019-06-14

Countries

  • Nigeria

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03468049 on ClinicalTrials.gov